OPTIMIZATION OF OBTAINING MEDICINAL PRODUCTS FROM PASSIFLORA IN THE FOOTHILL CONDITIONS OF THE FERGANA VALLEY
Том 4 № 68 (2026) 101-103
Аннотация
This paper examines the prospects for the cultivation and pharmaceutical processing of passiflora under the foothill conditions of the Fergana Valley. The necessity of optimizing the processes of cultivation, harvesting, drying, storage, and extraction of biologically active substances from plant raw materials is substantiated. Special attention is given to preserving the complex of flavonoids and other pharmacologically active compounds across various stages of technological processing. An integrated approach to obtaining standardized plant raw materials and passiflora-based medicinal products is proposed, taking into account regional natural and climatic features.
Ключевые слова:
Библиографические ссылки
World Health Organization. WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants. Geneva: World Health Organization, 2003.
European Medicines Agency. Assessment Report on Passiflora incarnata L., Herba. Committee on Herbal Medicinal Products (HMPC), EMA/HMPC/669738/2013, 2014.
European Pharmacopoeia. Passion Flower — Passiflora incarnata L. Ph. Eur. Monograph 1459. 10th ed. Strasbourg: European Directorate for the Quality of Medicines & HealthCare (EDQM), 2020.
Miroddinov, K., & Abdullayev, A. "Optimization of Extraction Parameters for Flavonoids from Cultivated Passiflora incarnata L." Uzbek Pharmaceutical Journal, vol. 18, no. 2, 2023, pp. 45–52.
Heinrich, M., Barnes, J., Gibbons, S., & Williamson, E. M. Fundamentals of Pharmacognosy and Phytotherapy. 3rd ed. Edinburgh: Elsevier, 2017.
География читателей
Загрузки
Опубликован
Выпуск
Раздел
Как цитировать